We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.33B
AUM Growth
+$70.1M
Cap. Flow
-$89.7M
Cap. Flow %
-3.85%
Top 10 Hldgs %
23.05%
Holding
203
New
5
Increased
30
Reduced
65
Closed
11

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$12.8M
2
IQV icon
IQVIA
IQV
+$8.32M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.79M
4
POOL icon
Pool Corp
POOL
+$7.16M
5
DVN icon
Devon Energy
DVN
+$6.82M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$29.3M
2
ACGL icon
Arch Capital
ACGL
+$24.2M
3
NEE icon
NextEra Energy
NEE
+$11.7M
4
FISV
Fiserv Inc
FISV
+$8.96M
5
ECL icon
Ecolab
ECL
+$6.6M

Sector Composition

Rank Sector Weight
1 Technology 33.52%
2 Industrials 18.51%
3 Financials 15.9%
4 Healthcare 15.48%
5 Consumer Discretionary 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
101
Bio-Rad Laboratories Class A
BIO
$8.71B
$5.72M 0.25%
13,600
– –
FIVN icon
102
FIVE9
FIVN
$2.11B
$5.69M 0.24%
83,900
– –
COO icon
103
Cooper Companies
COO
$14.1B
$5.69M 0.24%
68,800
– –
LSTR icon
104
Landstar System
LSTR
$5.93B
$5.51M 0.24%
33,800
-20
-0.1% -$3.21K
BABA icon
105
Alibaba
BABA
$293B
$5.11M 0.22%
58,000
-5,000
-8% -$394K
CRWD icon
106
CrowdStrike
CRWD
$194B
$4.74M 0.2%
180,000
– –
CVCO icon
107
Cavco Industries
CVCO
$4.22B
$4.71M 0.2%
20,800
– –
CSL icon
108
Carlisle Companies
CSL
$14.3B
$4.57M 0.2%
19,400
– –
HOOD icon
109
Robinhood
HOOD
$77.8B
$4.56M 0.2%
560,000
-100,000
-15% -$980K
KWR icon
110
Quaker Houghton
KWR
$2.76B
$4.46M 0.19%
26,700
– –
TWLO icon
111
Twilio
TWLO
$30B
$4.31M 0.18%
88,000
– –
TTC icon
112
Toro Company
TTC
$8.75B
$4.26M 0.18%
37,600
– –
SNAP icon
113
Snap
SNAP
$7.89B
$4.25M 0.18%
475,000
+55,000
+13% +$543K
AMN icon
114
AMN Healthcare
AMN
$1.3B
$4.18M 0.18%
40,651
– –
FN icon
115
Fabrinet
FN
$15.6B
$4.17M 0.18%
32,500
+1,300
+4% +$155K
ENS icon
116
EnerSys
ENS
$6.78B
$4.07M 0.17%
55,100
-3,000
-5% -$209K
PEN icon
117
Penumbra
PEN
$12.7B
$4.03M 0.17%
18,100
– –
SBUX icon
118
Starbucks
SBUX
$120B
$3.97M 0.17%
40,000
-5,052
-11% -$477K
BLD
119
DELISTED
TopBuild
BLD
$3.82M 0.16%
24,400
– –
TXRH icon
120
Texas Roadhouse
TXRH
$13.5B
$3.78M 0.16%
41,600
+7,000
+20% +$673K
TNET icon
121
TriNet
TNET
$3.02B
$3.76M 0.16%
55,400
– –
NKE icon
122
Nike
NKE
$61.9B
$3.74M 0.16%
32,000
-8,040
-20% -$810K
CRL icon
123
Charles River Laboratories
CRL
$11.2B
$3.7M 0.16%
17,000
– –
BCPC
124
Balchem Corp
BCPC
$5.38B
$3.7M 0.16%
30,300
– –
ZTS icon
125
Zoetis
ZTS
$32.4B
$3.66M 0.16%
25,000
-1,000
-4% -$148K
3 4
5
6 7

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, EULAV Asset Management held 203 positions worth $2.33B, up 3.1% from $2.26B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

EULAV Asset Management withdrew a net $89.7M in Q4 2022, closing 11 positions and reducing 65 holdings. Its most notable exit was Arch Capital, an estimated $24.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Financials.

Against the trend, EULAV Asset Management opened a new position in BioMarin Pharmaceuticals worth $8.59M.

  • EULAV Asset Management's largest Q4 2022 buy was BioMarin Pharmaceuticals: 83,000 shares worth $8.59M.
  • EULAV Asset Management added most to Idexx Laboratories in Q4 2022, an estimated $12.8M increase.
  • EULAV Asset Management's biggest Q4 2022 reduction was Danaher, cutting an estimated $29.3M.
  • EULAV Asset Management fully exited Arch Capital in Q4 2022, selling an estimated $24.2M.
  • EULAV Asset Management's ten largest holdings make up 23% of its $2.33B portfolio in Q4 2022.
  • EULAV Asset Management opened 5 new positions and closed 11 in Q4 2022.
  • EULAV Asset Management's portfolio value rose 3.1% quarter-over-quarter to $2.33B.

Based on EULAV Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.